Brokerages Set Nutrien Ltd (NYSE:NTR) Target Price at $61.00
Nutrien Ltd (NYSE:NTR) has been assigned an average recommendation of “Buy” from the eighteen analysts that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, five have given a hold recommendation, ten have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $61.00.
Several research analysts recently issued reports on the company. Raymond James set a $65.00 price objective on Nutrien and gave the stock a “strong-buy” rating in a research note on Wednesday, November 6th. Berenberg Bank reissued a “hold” rating and issued a $50.00 price objective on shares of Nutrien in a research note on Wednesday, November 6th. TheStreet raised Nutrien from a “c” rating to a “b-” rating in a research note on Friday, November 8th. ValuEngine raised Nutrien from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, Stifel Nicolaus dropped their target price on Nutrien from $63.00 to $62.00 and set a “buy” rating on the stock in a research report on Friday, October 4th.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Investors Research Corp grew its position in shares of Nutrien by 3.1% during the 2nd quarter. Investors Research Corp now owns 26,248 shares of the company’s stock valued at $1,403,000 after acquiring an additional 786 shares during the period. Carroll Financial Associates Inc. boosted its holdings in Nutrien by 11.1% in the 2nd quarter. Carroll Financial Associates Inc. now owns 2,843 shares of the company’s stock worth $152,000 after buying an additional 284 shares during the last quarter. Beech Hill Advisors Inc. boosted its holdings in Nutrien by 21.0% in the 2nd quarter. Beech Hill Advisors Inc. now owns 87,847 shares of the company’s stock worth $4,710,000 after buying an additional 15,240 shares during the last quarter. Legacy Capital Partners Inc. boosted its holdings in Nutrien by 7.3% in the 2nd quarter. Legacy Capital Partners Inc. now owns 5,860 shares of the company’s stock worth $313,000 after buying an additional 400 shares during the last quarter. Finally, Integrated Investment Consultants LLC boosted its holdings in Nutrien by 28.3% in the 2nd quarter. Integrated Investment Consultants LLC now owns 5,800 shares of the company’s stock worth $310,000 after buying an additional 1,280 shares during the last quarter. Institutional investors and hedge funds own 65.42% of the company’s stock.
Nutrien (NYSE:NTR) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.12). Nutrien had a net margin of 20.95% and a return on equity of 6.49%. The company had revenue of $4.13 billion for the quarter, compared to analysts’ expectations of $4.02 billion. During the same quarter last year, the company earned $0.47 earnings per share. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. Research analysts anticipate that Nutrien will post 2.38 earnings per share for the current year.
Nutrien Company Profile
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Read More: Index Funds
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.